3T. Jones,A. Stern,R. Lin.Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant[J]. European Journal of Clinical Microbiology & Infectious Diseases . 1994 (2)
4SondereggerI,IezziG,MaierR,etal.GM-CSF mediates au-toimmunitybyenhancingIL-6-dependentTh17 cell develop-ment and survival. The Journal of Experimental Medicine . 2008
5Melkebeek V,Verdonck F,Stuyven E,et al.Plasmid-en-coded GM-CSF induces priming of the F4 (K88)-specificserum IgA response by FaeG DNA vaccination in pig. Vaccine . 2006
6Zaharoff DA,Rogers CJ,Hance KW,et al.Chitosan solu-tion enhances the immunoadjuvant properties of GM-CSF. Vaccine . 2007
7Qing YI,Chen M,Zhao JJ,et al.Construction of an HBVDNA vaccine by fusion of the GM-CSF gene to theHBV-S gene and examination of its immune effects in nor-mal and HBV-transgenic mice. Vaccine . 2010
8Verkade MA,Wetering JVD,Klepper M,et al.Peripheralblood dendritic cells and GM-CSF as an adjuvant for hepati-tis B vaccination in hemodialysis patients. Kidney International . 2004
9Hirata Y,Egea L,Dann SM,et al.GM-CSF-facilitated den-dritic cell recruitment and survival govern the intestinalmucosal response to a mouse enteric bacterial pathogen. Cell Host&Microbe . 2010
10C Hartoonian,M Ebtekar,H Soleimanjahi,A Karami,M Mahdavi,N Rastgoo,K Azadmanesh.Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine. Cytokine . 2009
